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Abstract
We aimed at investigating whether the frequency and function of T helper 17 (Th17) and
regulatory T cells (Treg) are affected by a restriction of dietary sodium intake in patients with
rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). We enrolled RA and
SLE patients not receiving drugs known to increase urinary sodium excretion. Patients
underwent a dietary regimen starting with a restricted daily sodium intake followed by a nor-
mal-sodium daily intake. The timepoints were identified at baseline (T0), after 3 weeks of
low-sodium dietary regimen (T3), after 2 weeks of normal-sodium dietary regimen (T5). On
these visits, we measured the 24-hour urinary sodium excretion, the frequency and function
of Th17 and Treg cells in the peripheral blood, the serum levels of cytokines. Analysis of uri-
nary sodium excretion confirmed adherence to the dietary regimen. In RA patients, a trend
toward a reduction in the frequencies of Th17 cells over the low-sodium dietary regimen fol-
lowed by an increase at T5 was observed, while Treg cells exhibited the opposite trend.
SLE patients showed a progressive reduction in the percentage of Th17 cells that reached
a significance at T5 compared to T0 (p = 0.01) and an increase in the percentage of Treg
cells following the low-sodium dietary regimen at both T1 and T3 compared to T0 (p = 0.04
and p = 0.02, respectively). No significant apoptosis or proliferation modulation was found.
In RA patients, we found a reduction at T5 compared to T0 in serum levels of both TGFβ
(p = 0.0016) and IL-9 (p = 0.0007); serum IL-9 levels were also reduced in SLE patients at
T5 with respect to T0 (p = 0.03). This is the first study investigating the effects of dietary
sodium intake on adaptive immunity. Based on the results, we hypothesize that a restricted
sodium dietary intake may dampen the inflammatory response in RA and SLE patients.
Introduction
Rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) are chronic autoimmune
diseases sustained by impaired immunoregulatory processes alongside environmental factors
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in genetically susceptible individuals [1]. Among the environmental factors, hormones, ciga-
rette smoking, and microbial agents have been implicated as favouring incident cases of both
diseases; in addition, silica exposure and excess body mass have been considered for RA and
exposure to ultraviolet light for SLE [2].
More recently, the role of dietary factors has gained interest due to the results of 2 indepen-
dent studies, in which a modulation in T cells immune response was observed after a few
weeks in murine models of autoimmune diseases following an excess salt intake [3,4]. Both
studies demonstrated that high concentrations of sodium chloride promote the differentiation
of T helper (Th) lymphocytes toward the Th17 phenotype, known to be highly pro-inflamma-
tory [5], and the Th17-modulating effects of sodium chloride were found to be critical for the
development of experimental autoimmune encephalomyelitis, an animal model for multiple
sclerosis (MS) [3].
Up to now, only 2 studies in humans aimed at ascertain whether a surplus in sodium
dietary intake may affect the emergence of autoimmune diseases [6,7]. In the former, a
nested case-control study was set up in patients with RA to take advantage of the data
obtained since 1991 among the citizens of a county in northern Sweden, who had been
invited to participate in a screening and intervention programme for risk factors for car-
diovascular diseases. Although no significant association was found between sodium intake
and the development of RA, in further analyses adjusting for defined risk factors for RA
significant associations were observed among smokers, in whom sodium intake more than
doubled the risk of developing RA. Additive interaction analyses suggested that approxi-
mately half of the amount of risk from smoking in the development of RA was due to inter-
action with sodium intake [6]. In the second study, sodium intake was estimated from
urinary sodium excretion in 70 patients with relapsing-remitting MS observed for 2 years.
Not only was a positive correlation found between exacerbation rate and sodium intake in
a multivariate model but, interestingly, individuals with high-sodium intake had a greater
chance of developing a new lesion on the brain and spinal cord magnetic resonance imag-
ing. However, a clear association between dietary sodium intake and disease activity could
not be claimed because the cohort size was relatively small, the serum sodium levels
remained rather constant under different dietary conditions, and the exclusion of con-
founders was not possible [7].
Overall, both experimental and clinical studies support the possibility that a high dietary
sodium intake may promote the pro-inflammatory response in autoimmune diseases, possibly
via the activation of Th17 lymphocytes. It was believed that Th17 cells were functionally antag-
onists to regulatory T cells (Treg), which are pivotal for controlling autoimmunity, and the
dichotomy was also extended to their generation [8]. This view has subsequently changed,
when studies revealed that Th17 and Treg cells may develop from the same precursors under
distinct cytokine conditions [9] and a subset of IL-17-producing Treg cells can be generated
upon polarization by cytokines [10].
Since no data are available on the biological effects of excess sodium in patients with auto-
immune diseases, the aim of the present study was to investigate whether the frequency and
function of Th17 and Treg cells are affected by a restriction of dietary sodium intake in RA
and SLE patients observed over a five-week period.
Patients and methods
Patient population
The study received Policlinico Umberto I Ethics Committee approval in accordance with local
requirements (prot. n. 1256/14) and written informed consent was obtained from each
Dietary sodium intake and risk of autoimmune diseases
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participant. Between October 2014 and March 2016, we enrolled consecutive Caucasian RA
and SLE patients fulfilling the ACR/EULAR 2012 [11] and ACR 1997 [12] classification crite-
ria, respectively. A prednisone dose of>5 mg/day or equivalent was considered as an exclu-
sion criterion based on the findings that glucocorticoids increase urine volume, promote
urinary sodium and potassium excretion, and affect the capability of mineralcorticoids to
retain sodium [13]. Likewise, none of the patients were taking other drugs known to increase
urinary sodium excretion including thiazide diuretics, potassium-sparing diuretics, loop
diuretics, angiotensin converting enzyme-inhibitors, and angiotensin II AT1 receptor antago-
nists [14–16]. Other treatments, including immunosuppressants, were allowed provided that
were taken at a stable dose for at least 4 weeks prior to the baseline visit and patients were
asked to remain on a stable dose throughout the study period. None of them were on a weight-
loss diet and/or used dietary supplements.
Study design
The study was planned to cover a five-week period and has a within-subjects design in which
all of the participants served as their own control. Given the harmful effects of excess sodium
consumption [17], patients underwent a dietary regimen starting with a restricted daily
sodium intake followed by a normal-sodium daily intake, thus avoiding the exposure to a sur-
plus in sodium dietary intake. The first week served as the “run-in” period, allowing patients
to get used to the low-sodium diet following the indications in the leaflet given to each of them
(Supplementary Material). The intent was to measure the adherence to the diet and the coun-
tercheck was provided by testing the 24-hour urine excretion of sodium at the end of the week.
This was supposed to be<85 mEq/die, based on the assumption that a low-sodium dietary
regimen is defined by<5 grams of sodium chloride a day [18] and that 1 gram of sodium chlo-
ride contains 17 mEq of sodium [19]. If the 24-hour urinary sodium excretion target was met,
patients were asked to continue the low-sodium diet regimen for other 2 weeks and, again,
another control of urinary sodium excretion was performed to check for the adherence to diet.
Finally, patients entered the last 2 weeks of the study, which were devoted to a normal-sodium
dietary regimen. To achieve this goal, they were given a total of 70 bags of cooking sodium
(each containing 1 gram of sodium) to enrich their low-sodium intake diet (5 grams a day). At
the end of the study, the 24-hour urinary sodium excretion was determined.
The main timepoints of the study were identified at baseline, before starting the low-
sodium dietary regimen (T0); after 3 weeks, at the end of low-sodium dietary regimen (T3); at
the end of the study, after 2 weeks of normal-sodium dietary regimen (T5). As mentioned, on
these visits we measured the 24-hour sodium excretion in urine, which is considered the most
reliable method for measuring urinary sodium excretion and an accepted estimate of sodium
intake [20,21]. Furthermore, patients underwent venous blood sampling to analyze the fre-
quency of Th17 and Treg cells as well as their function through analysis of apoptosis and pro-
liferation; serum was also obtained for cytokine measurements.
Preparation of PBMCs and flow cytometry analysis to identify Th17 and
Treg cells
PBMCs were isolated by Ficoll-Hypaque density-gradient centrifugation [22] to identify Th17
cells, defined as IL-17 expressing CD4+ T cells [23], and Treg cells, defined as CD4+FoxP3+ T
cells [24]. Surface and intracellular phenotyping of PBMCs was performed with combinations of
fluorescein isothiocyanate (FITC), phycoerythrin (PE), peridinin chlorophyll protein (PerCP) or
allophycocyanin (APC)-labelled monoclonal antibodies (mAbs) as described before [25]. For
surface staining, conjugated mAbs against human CD4, CD45RA and CD25 (all from BD
Dietary sodium intake and risk of autoimmune diseases
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Biosciences, San Jose, CA, USA) were used. The intracellular detection of IL-17, FoxP3 and Ki-
67 with PerCP-labelled anti-IL-17 (clone eBio64DEC17; eBioscience), PE-labelled anti-FoxP3
(clone 236A/E7; eBioscience), and PerCP-labelled anti-Ki-67 (BD Biosciences) was obtained on
cells fixed and permeabilized using Fix/Perm solution (eBioscience). For the detection of intra-
cellular IL-17 production, PBMCs were stimulated for 4 hours with 50 ng/ml phorbol 12-myris-
tate 13-acetate (PMA) and 1 μg/ml ionomycin in the presence of 10 μg/ml Brefeldin A (all from
Sigma-Aldrich, St. Louis, MO, USA), and then stained with PerCP-labelled anti-IL-17 mAb after
fixation and permeabilization. Among Treg cells, we measured the 3 functionally distinct subsets
that were recently recognized [24]: the naïve or resting Treg cells (nTreg), defined by the CD4+-
CD45RA+FoxP3low phenotype; the effector or activated Treg cells (eTreg), defined by the CD4+-
CD45RA-FoxP3high phenotype; the FoxP3 expressing non-regulatory Treg cells (non-Treg),
defined by the CD4+CD45RA-FoxP3low phenotype, which exhibit the capability to trans-differ-
entiate into Th17 cells in the presence of a favourable local cytokine milieu.
Preparation of PBMCs to detect apoptosis and lymphocytes proliferation
Spontaneous apoptosis of PBMCs was measured immediately following lymphocyte separation
(ex vivo apoptosis) using FITC-conjugated annexin V (AV) and propidium iodide (PI) apoptosis
detection kit (Marine Biological Laboratory, Woods Hole, MA) according to the manufacturer’s
protocol. The combination of FITC-conjugated AV and PI allows the differentiation among early
apoptotic cells (AV+PI-), late apoptotic cells (AV+PI+), dead cells (AV-PI+), and total apoptosis
(AV++, including early and late apoptotic cells). Finally, the proliferation of CD4+ T lymphocytes
was evaluated by measuring the expression of the human Ki-67 protein, which is considered an
excellent marker for determining the growth fraction of a cell population because it is present
during all active phases of the cell cycle and mitosis but it is absent from resting cells [26]. Cells
were detected by sequential gating for CD4+, CD45RA+, and FoxP3low/high. For gating strategy of
the analysis of Th17 and Treg cells, see Fig 1. Acquisition was performed on a FACSCalibur
cytometer (BD Immunocytometry Systems), and the data were analyzed using CellQuest Pro
software (BD Immunocytometry Systems, San Jose, CA).
Enzyme-linked immunosorbent assay (ELISA) to detect serum cytokines
Sera were obtained at T0, T3 and T5 by standard methods and stored at -80˚C until used. We
decided to measure the levels of IFNα, TGFβ1, IL-23, IL-1β, IL-6, IL-9, IL-12, IL-17, and TNF,
due to their known pro-inflammatory/immunoregulatory properties. Serum IFNα concentra-
tions were determined using a commercially available ELISA kit (R&D Systems, Minneapolis,
MN) following the manufacturer’s instructions. The other cytokines were assessed using a
cytokine panel by Bio-Plex assays (Bio-Rad Laboratories, Richmond, CA, USA) following the
manufacturer’s instructions. Data were analyzed using the Bio-Plex Manager software, version
4.1.1 (Bio-Rad Laboratories), reported as fluorescence intensity (FI) and subsequently con-
verted into concentration (pg/ml).
Statistical analysis
Data are expressed as median/25th-75th percentile or percentages when appropriate. The com-
parison of percentages was performed using the χ2 test or Fisher’s exact test when appropriate.
The comparisons for continuous variables between patients with RA and SLE was made with
the Mann-Whitney test, while multiple comparisons in patients at different times was made
with the Friedman test with Dunn correction for dependent samples. The significance of any
correlation was determined by Spearman’s rank correlation coefficient. P values <0.05 indi-
cated statistical significance.
Dietary sodium intake and risk of autoimmune diseases
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Statistical analysis was performed using GraphPad Prism 6 software (GraphPad Software,
San Diego, CA, USA).
Results
Clinical and demographic characteristics of patient population
The clinical and demographic characteristics of patients with RA and SLE are presented in Tables
1 and 2, respectively. Overall, 60 patients were approached, but only 30 (15 with RA and 15 with
SLE) were willing to participate and signed the informed consent; among these, one patient with
RA failed to undergo the low sodium dietary regimen and withdrew after 3 weeks. Demographic
parameters were balanced between the 2 groups with the exception of age, which was significantly
higher in patients with RA with respect to those with SLE (p = 0.0008). Disease activity was evalu-
ated at baseline in patients with RA by DAS28 [27], and in patients with SLE by SLEDAI-2K [28].
The disease activity was low in accordance with the need to take a low dose of glucocorticoids for
patients to be enrolled and, based on the short duration of the study and on stable treatment dur-
ing follow-up, we decided not to reevaluate disease activity at the end of the study.
Adherence to the dietary regimen according to the study design
To prove the adherence to the diet, 24-hour urinary sodium excretion was measured at T0,
T1, T3, and T5. The results confirmed the correct attitude of the patients to the new dietary
regimen throughout the study. In patients with RA, levels of urinary sodium excretion
Fig 1. Representative dot plots of peripheral blood lymphocytes from one patient showing the gating strategy to identify Th17 and Treg cells.
(A) Live cells, gated for cell death and debris exclusion, were then gated as lymphocytes (R1) based on morphological parameters (SSC, side scatter;
FSC, forward scatter). (B) Identification of CD4+ lymphocytes (R2) within the R1 population. (C) Identification of Treg cells and (D) Th17 cells within the R2
population. (E) Identification of the I, II and III fractions of Treg cells within the R2 population. The values were expressed as percentage of CD4+ T cells.
https://doi.org/10.1371/journal.pone.0184449.g001
Dietary sodium intake and risk of autoimmune diseases
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(median/25th-75th percentile) significantly decreased from T0 (113.5/84.9–165.5) to T1 (47.5/
36.9–71.3; p<0.0001) and from T0 to T3 (49.6/36.6–72; p<0.001), and increased from T1 to
T5 (95.5/82.1–170.7; p<0.01) and from T3 to T5 (p<0.001). In patients with SLE, levels of uri-
nary sodium excretion significantly decreased from T0 (153/96.3–215) to T1 (48/35-72.7;
p = 0.0001) and from T0 to T3 (46/40.3–55; p<0.0001), and increased from T3 to T5 (102/
74.4–124.3; p = 0.02) (Fig 2A and 2B).
Change of Th17 and Treg cell frequencies alongside dietary regimen
We investigated the change in the frequencies of Th17 and Treg cells (including the nTreg,
eTreg, and non-Treg fractions) in the peripheral blood of patients with RA and SLE following a
dietary regimen characterized by the modulation of sodium intake. As shown in Fig 3A, we did
not find any significant change in the frequencies of Th17 cells in RA patients, although a clear
trend toward a reduction over the low-sodium dietary regimen followed by an increase at the
end of the study was observed. Similarly, no significant change was observed in the frequencies
of Treg cells, despite a trend toward an increase during the low-sodium intake with respect to
baseline and a decrease at the end of normal sodium regimen (Fig 3B). Among the different sub-
types of Treg cells, the frequency of non-Treg fraction producing IL-17 significantly decreased at
the end of the study with respect to baseline (8.1/3.04–12.4 vs 1.6/0.6–2.5; p<0.01) (Fig 3C).
In SLE patients, we found a progressive reduction in the percentage of Th17 cells that
reached a statistical significance at T5 (0.5/0.4–0.7) compared to T0 (0.7/0.5–1; p = 0.01)
(Fig 4A), and a significant increase in the percentage of Treg cells following the low-sodium
dietary regimen at both T1 (4.1/2.5–5.7) and T3 (4.9/3.7–6) compared to T0 (3.7/2.4–4.1;
Table 1. Demographic, clinical, serological and therapeutic features of patients with rheumatoid
arthritis (n = 14).
Females, no. 13
Age, median/25˚-75˚ percentile years 58.5 (50–67)
Disease duration, median/25˚-75˚ percentile months 72 (33–225)
DAS28 by ESR, median/25˚-75˚ percentile 3.2 (2.4–3.8)
SEROLOGICAL FEATURES, no. (%)
RF+ 10 (71.4)
ACPA+ 6 (42.8)
ACPA+/RF+ 6 (42.8)
ACPA-/FR- 4 (28.6)
ESR, median/25˚-75˚ percentile mm/h 13 (6.5–19.2)
CRP, median/25˚-75˚ percentile mg/dl 0.05 (0–0.3)
CIGARETTE SMOKING, no. (%)
Smokers 2 (14.3)
Non-smokers 7 (50)
Ex-smokers 5 (35.7)
CONCOMITANT TREATMENT
Glucocorticoids, no. (%) 6 (42.8)
Weekly dose of PDN, median/25˚-75˚ percentile mg 0/0-35
DMARDs, no. (%) 7 (50)
Biologic DMARDs, no. (%) 7 (50)
DAS28 = disease activity score; ESR = erythrocyte sedimentation rate; RF = rheumatoid factor;
ACPA = anticitrullinated protein antibody; CRP = C-reactive protein; PDN = prednisone;
DMARDs = disease-modifying antirheumatic drugs.
https://doi.org/10.1371/journal.pone.0184449.t001
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p = 0.04 and p = 0.02, respectively) (Fig 4B). Examining the different fractions of Treg cells,
a significant increase in the percentage of non-Treg cells at T3 (3.4/2.3–4) compared to T0
(2.6/1.5–3; p = 0.02) was found, as shown in Fig 4C.
Detection of PBMC apoptosis and lymphocytes proliferation
Spontaneous apoptosis of PBMCs was evaluated at the main timepoints of the study. Neither
in RA nor in SLE patients we found any significant apoptosis or proliferation modulation dur-
ing the two dietary sodium regimens (not shown).
Table 2. Demographic, clinical, serological and therapeutic features of patients with systemic lupus
erythematosus (n = 15).
Female, no. 15
Age, median/25˚-75˚ percentile years 44 (30–50)
Disease duration, median/25˚-75˚ percentile months 108 (48–264)
CLINICAL FEATURES, no. (%)
Skin 6 (40)
Joint 14 (93.3)
Serositis 1 (6.7)
Hematological 8 (53.3)
Renal 3 (20)
NPSLE 0
SEROLOGICAL FEATURES, no. (%)
ANA 15 (100)
Anti-dsDNA 9 (60)
Anti-ENA 7 (46.7)
Anti-SSA 6 (40)
Anti-SSB 1 (6.7)
Anti-Sm 1 (6.7)
Anti-RNP 1 (6.7)
anti-CL IgG/IgM 7 (46.7)
anti-β2GPI IgG/IgM 5 (33.3)
LAC 3 (20)
Low C3 and C4 level 9 (60)
CLINIMETRICS
SLEDAI-2K, median/25˚-75˚ percentile 2 (0–4)
CIGARETTE SMOKING, no. (%)
Smokers 3 (20)
Non-smokers 8 (53.3)
Ex-smokers 4 (26.7)
CONCOMITANT TREATMENT
Glucocorticoids, no. (%)
Weekly dose of PDN, median/25˚-75˚ percentile mg
6 (40)
0/0-10
Hydroxychloroquine, no. (%) 12 (80)
Immunosuppressive drugs, no. (%) 3 (20)
Anti-BLyS, no. (%) 2 (13.3)
NPSLE: neuropsychiatric systemic lupus erythematosus; ANA = antinuclear antibodies; Anti-dsDNA = anti-
double-stranded DNA; LAC = lupus anticoagulant; C3 = complement fraction 3; C4 = complement fraction 4;
SLEDAI-2K = Systemic Lupus Erythematosus Disease Activity Index 2000; PDN = prednisone; Anti-
BLyS = anti-B-lymphocyte stimulator.
https://doi.org/10.1371/journal.pone.0184449.t002
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Fig 2. Comparison of urinary sodium excretion (mEq/24h) between the main timepoints of the study set at T0 (baseline, before starting the low-
sodium dietary regimen), T1 (after 1 week, at the end of the “run-in” period of low-sodium dietary regimen), T3 (after 3 weeks, at the end of low-
sodium dietary regimen), and T5 (at the end of the study, after 2 weeks of normal sodium dietary regimen). (A) In patients with rheumatoid arthritis,
levels of 24-hour urinary sodium excretion significantly decreased from T0 to T1 and from T0 to T3 (after 3 weeks, at the end of low-sodium dietary regimen),
and increased from T1 to T5 (at the end of the study, after 2 weeks of normal sodium dietary regimen) and from T3 to T5. (B) In patients with systemic lupus
erythematosus, levels of 24-hour urinary sodium excretion significantly decreased from T0 to T1 and from T0 to T3, and increased from T3 to T5. Data are
shown as Tukey boxplots; lines represent the median level with 25th-75th percentile; data not included between the whiskers are plotted as outliers with dots.
https://doi.org/10.1371/journal.pone.0184449.g002
Fig 3. Change in the frequencies of Th17 and Treg cells (including the nTreg, eTreg, and non-Treg
fractions) in the peripheral blood of patients with rheumatoid arthritis at the main timepoints of the
study set at T0 (baseline, before starting the low-sodium dietary regimen), T1 (after 1 week, at the end
of the “run-in” period of low-sodium dietary regimen), T3 (after 3 weeks, at the end of low-sodium
dietary regimen), and T5 (at the end of the study, after 2 weeks of normal sodium dietary regimen). (A)
No significant change in the frequencies of Th17 cells between the main timepoints of the study. (B) No
significant change in the frequencies of Treg cells between the main timepoints of the study. (C) The
frequency of non-Treg fraction of Treg cells (exhibiting the capability to trans-differentiate into Th17 cells and
indeed being positive for the intracellular staining with IL-17 mAb) significantly decreased at the end of the
study with respect to baseline. Data are shown as Tukey boxplots; lines represent the median level with 25th-
75th percentile; data not included between the whiskers are plotted as outliers with dots.
https://doi.org/10.1371/journal.pone.0184449.g003
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Levels of serum cytokines
Levels of pro-inflammatory/immunoregulatory cytokines involved in the pathogenesis of RA
and SLE were analyzed to find possible changes alongside dietary sodium intake. In RA
patients, we found a significant reduction at T5 compared to T0 in serum levels (pg/ml) of
both TGFβ1 (3002/2193-37069 vs 49069/38221-58005; p = 0.0016) and IL-9 (1.65/0-17.5 vs
12.8/3-41.2; p = 0.0007) (Fig 5A and 5B, respectively). Serum IL-9 levels were also reduced in
SLE patients at T5 with respect to T0 (0/0-2.25 vs 2.3/0-11.2; p = 0.03) as shown in Fig 5C. No
significant differences were observed in the other cytokines measured (not shown).
Discussion
To our knowledge, this is the first study investigating the effects of dietary sodium intake on
adaptive immune response in patients with autoimmune diseases.
Patients with RA and SLE accepted to undergo a five-week period of a composite dietary
regimen starting with a restricted daily sodium intake followed by a normal-sodium daily
intake. RA and SLE are multifactorial diseases whose genetic and environmental factors are
continually being explored [1].
Among environmental factors, dietary regimen is receiving growing attention, due to the
capability of affecting inflammation, antigen presentation, antioxidant defense mechanisms,
allergies and gut microbiota [29]. Furthermore, modest increases in the concentration of
sodium chloride markedly enhanced pro-inflammatory Th17 responses in vitro, as did a high-
sodium diet in vivo, in 2 independent studies in murine models of autoimmune diseases [3,4].
These studies also provide possible hints on the molecular mechanisms by which sodium chlo-
ride may sustain the inflammatory responses. In the former, a modest increase in NaCl
Fig 4. Change in the frequencies of Th17 and Treg cells (including the nTreg, eTreg, and non-Treg
fractions) in the peripheral blood of patients with systemic lupus erythematosus at the main
timepoints of the study set at T0 (baseline, before starting the low-sodium dietary regimen), T1 (after 1
week, at the end of the “run-in” period of low-sodium dietary regimen), T3 (after 3 weeks, at the end of
low-sodium dietary regimen), and T5 (at the end of the study, after 2 weeks of normal sodium dietary
regimen). (A) Reduction in the percentage of Th17 cells at T5 compared to T0. (B) Significant increase in the
percentage of Treg cells at both T1 and T3 compared to T0. (C) Significant increase in the percentage of non-
Treg cells at T3 compared to T0. Data are shown as Tukey boxplots; lines represent the median level with
25th-75th percentile; data not included between the whiskers are plotted as outliers with dots.
https://doi.org/10.1371/journal.pone.0184449.g004
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concentration could stimulate an almost logarithmic in vitro induction of IL-17A in naïve
CD4+ cells mediated through p38/MAPK, nuclear factor of activated T cells 5 (NFAT5) and
serum/glucocorticoid-regulated kinase 1 (SGK1); importantly, the addition of 40 mM of NaCl
to Th17 differentiaton cultures not only increased IL-17A expression but also led to a patho-
genic phenotype of Th17 cells [3]. Likewise, in the latter study, a modest increase in salt con-
centration induced SGK1 expression, promoting IL-23R expression and enhancing Th17 cell
differentiation in vitro and in vivo [4].
Since then, studies in humans with RA and MS proved further consistency on the role of excess
sodium intake in favouring the development or exacerbation of these diseases, although no biolog-
ical effect was tested [6,7]. Yet, the issue is of utmost importance, since salt content in processed
foods and ‘fast food’ largely consumed in the Western countries can be more than 100 times
higher in comparison to similar homemade meals [30]. Notably, there is a high prevalence of auto-
immune diseases in Western societies than in the Eastern world and developing countries [31,32].
Also, the more recent European guidelines on cardiovascular disease prevention reaffirm the rec-
ommendation to not exceed 5 grams of salt per day [18]. This was the threshold of sodium intake
for the patients enrolled in our study in the normal sodium phase, which was preceded by a dietary
sodium restriction. Adherence to the dietary regimen was demonstrated by the levels of 24-hour
urinary sodium excretion which were widely lower than the established cut-off of 85 mEq/24h at
scheduled timepoints to ascertain the restricted sodium intake in the first 3 weeks. Interestingly,
the levels of 24-hour urinary sodium excretion at baseline (median/25˚-75˚ percentile) were high
(113.5/84.9–165.5 and 153.5/96.3–215 for RA and SLE patients, respectively), confirming that in
most Western countries sodium intake usually exceed the recommended limit [18].
The adoption of healthier dietary habits with low sodium intake is known to influence cardio-
vascular risk [33] and gastric cancer [34]; our study shows also evidence of an anti-inflammatory
Fig 5. Levels (pg/ml) of pro-inflammatory/immunoregulatory cytokines measured in the serum of
patients with RA and SLE at the main timepoints of the study set at T0 (baseline, before starting the
low-sodium dietary regimen), T1 (after 1 week, at the end of the “run-in” period of low-sodium dietary
regimen), T3 (after 3 weeks, at the end of low-sodium dietary regimen), and T5 (at the end of the study,
after 2 weeks of normal sodium dietary regimen). (A) Significant reduction in serum TGFβ1 levels and (B)
IL-9 levels at T5 compared to T0 in patients with rheumatoid arthritis. (C) Significant reduction in serum IL-9
levels in patients with systemic lupus erythematosus at T5 with respect to T0. Data are shown as Tukey
boxplots; lines represent the median level with 25th-75th percentile; data not included between the whiskers
are plotted as outliers with dots.
https://doi.org/10.1371/journal.pone.0184449.g005
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effect in autoimmune diseases. The finding was overt in patients with SLE, who exhibited a pro-
gressive reduction in the percentage of the pro-inflammatory Th17 cells over the 5 weeks of the
study and a parallel increase in the percentage of Treg cells following the low-sodium dietary reg-
imen. A similar change in the frequencies of Th17 cells and Treg cells was observed in patients
with RA, although the comparisons between the different timepoints did not reach a statistical
significance. This is the first demonstration of the induction of biological effects of sodium on
adaptive immunity ex vivo in patients with autoimmune diseases, while a modulation of macro-
phages which resulted skewed toward a pro-inflammatory [35,36] or an anti-inflammatory phe-
notype and function had already been reported [37].
Another data supporting a beneficial effect a low-sodium dietary regimen derives by the
observation that IL-9 serum levels in RA and SLE patients significantly decreased from base-
line to the end of the study. This is in line with previous findings in vitro, demonstrating that
high sodium chloride concentration led Th17 to display a pathogenic phenotype, characterized
by the expression of pro-inflammatory cytokines, including IL-9 [3]. This cytokine is produced
by activated T cells and supports the growth of Th but not cytolytic clones and has pleiotropic
functions on the immune system [38,39]. Recent studies provided evidence of a pro-inflamma-
tory role of IL-9 in RA patients, where IL-9 and Th9 cells were overexpressed in synovial tissue
and correlated with the degree of histological organization of B and T cells in ectopic lymphoid
structures [40]. Furthermore, peripheral blood Th9 cells were increased in patients with estab-
lished and early untreated RA with respect to healthy controls, and expanded after in vitro
exposure to citrullinated aggrecan peptide [40]. In lupus murine models, an expansion of Th9
cells in the spleens of lupus-prone mice was demonstrated and also serum IL-9 levels were ele-
vated, which were positively correlated to anti-dsDNA antibody titer [41]. Although in SLE
patients higher IL-9 serum levels than controls were observed, no associations with disease
activity, chronic damage and clinical features were found [42]. Notably, TGFβ1, a regulatory
cytokine that affects proliferation, differentiation, and survival of several types of cells, pro-
motes the redirection of naI¨ve T cells from a Th2 to Th9 cell differentiation pathway [43] and
was abundantly seen in most actively proliferating synovial intimal cells from patients with RA
[44]. Furthermore, while a protective effect of TGFβ1 in collagen-induced arthritis (CIA) was
demonstrated [45], other evidences showed that the local inhibition of TGFβ1 by a neutraliz-
ing antibody suppressed acute and chronic arthritis in an experimental model of chronic ero-
sive polyarthritis [46]. These findings suggest that the pleiotropic effects of TGFβ are context-
related and, indeed, in our RA patients the sodium restriction induced a dramatic reduction of
TGFβ1 serum levels in a context of reduced inflammatory burden.
In conclusion, this is the first study investigating the effects of cooking salt in adaptive
immunity ex vivo in patients with RA and SLE, suggesting that a restricted sodium dietary
intake could contribute to dampen the pro-inflammatory response. Our results add informa-
tion on a potential new modifiable environmental factor in autoimmune diseases; however,
due to the limited sample size, further studies are encouraged to define the utility and modality
of dietary habits to ameliorate the outcome in these patients.
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